Enhancing progenitor cells for cell therapy after myocardial infraction
<p>Based on data from the World Healthcare Organisation, cardiovascular diseases are the primary cause of disease-related death globally, with myocardial infarction (MI) being the most prevalent. If not treated effectively, MI can progress to heart failure (HF). With 70 million prescriptions f...
Main Author: | Malandraki-Miller, S |
---|---|
Other Authors: | Carr, C |
Format: | Thesis |
Published: |
2016
|
Similar Items
-
Changing metabolism in differentiating cardiac progenitor cells - can stem cells become metabolically flexible cardiomyocytes?
by: Malandraki-Miller, S, et al.
Published: (2018) -
Beneficial effects of statin treatment after myocardial infarction: Is progenitor cell mobilization the missing link?
by: Tousoulis, D, et al.
Published: (2008) -
Risk factor profile of patients presenting with acute ST-elevation myocardial infraction to a rural hospital in Malaysia
by: Mohd Shah, Azarisman Shah, et al.
Published: (2008) -
Development of mobile road traffic infraction registration system
by: Rad, Habibollah Arasteh
Published: (2010) -
Stem cell therapy for the heart: blind alley or magic bullet?
by: Bruyneel, A, et al.
Published: (2016)